Abstract
Herein we report a case of a cystic fibrosis child who was simultaneously infected with Burkholderia cepacia genomovar III and Burkholderia vietnamiensis. After antimicrobial therapy only B. cepacia genomovar III persisted.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amikacin / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
Burkholderia / genetics
-
Burkholderia / isolation & purification*
-
Burkholderia Infections / complications*
-
Burkholderia Infections / drug therapy
-
Burkholderia Infections / microbiology*
-
Burkholderia cepacia complex / genetics
-
Burkholderia cepacia complex / isolation & purification
-
Ciprofloxacin / therapeutic use
-
Cystic Fibrosis / complications*
-
Cystic Fibrosis / microbiology*
-
Drug Resistance, Bacterial / genetics
-
Humans
-
Infant
-
Male
-
Respiratory Tract Infections / complications*
-
Respiratory Tract Infections / drug therapy
-
Respiratory Tract Infections / microbiology*
-
Treatment Outcome
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Substances
-
Anti-Infective Agents
-
Ciprofloxacin
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Amikacin